This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Tomer Cohen - Innovator in Immunology
Introduction
Tomer Cohen is an accomplished inventor based in Rehovot, Israel. With a focus on innovative solutions in the field of immunology, he has made significant strides, as evidenced by his sole patent in the realm of therapeutic peptides.
Latest Patents
Cohen holds a patent titled "Peptides derived from HIV-1 gp41 transmembrane domain for T-immunomodulation." This invention encompasses peptides, derivatives, and analogs that comprise an amino acid sequence derived from the transmembrane domain of the HIV gp41 protein. The pharmaceutical compositions developed from this innovation are aimed at treating inflammatory diseases and disorders, particularly those mediated by T-cells and monocytes.
Career Highlights
Cohen is currently affiliated with Yeda Research and Development Company Ltd., where he continues to push the boundaries of medical research and invention. His work has the potential to impact the treatment options available for various inflammatory conditions.
Collaborations
Throughout his career, Cohen has collaborated with notable colleagues, including Yechiel Shai and Irun R. Cohen. These partnerships reflect a shared commitment to advancing healthcare solutions through innovative research and development.
Conclusion
Tomer Cohen exemplifies the spirit of innovation in the biomedical field. His contributions through patenting unique therapeutic peptides highlight his dedication to improving patient outcomes in inflammatory diseases, marking him as a valuable figure in the research landscape of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile